Literature DB >> 16230457

Clinical usefulness of B-type natriuretic peptide measurement: present and future perspectives.

Paulo M Bettencourt1.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16230457      PMCID： PMC1769197          DOI： 10.1136/hrt.2005.063784

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  9 in total

1.  Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations.

Authors:  R W Troughton; C M Frampton; T G Yandle; E A Espiner; M G Nicholls; A M Richards
Journal:  Lancet       Date:  2000-04-01       Impact factor: 79.321

Review 2.  BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases.

Authors:  Marc A Silver; Alan Maisel; Clyde W Yancy; Peter A McCullough; John C Burnett; Gary S Francis; Mandeep R Mehra; William Franklin Peacock; Gregg Fonarow; W Brian Gibler; David A Morrow; Judd Hollander
Journal:  Congest Heart Fail       Date:  2004 Sep-Oct

3.  Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT).

Authors:  Roberto Latini; Serge Masson; Inder Anand; Dianne Judd; Aldo P Maggioni; Yann-Tong Chiang; Maurizio Bevilacqua; Monica Salio; Paola Cardano; Peter H J M Dunselman; Nicolaas J Holwerda; Gianni Tognoni; Jay N Cohn
Journal:  Circulation       Date:  2002-11-05       Impact factor: 29.690

4.  Biochemical detection of left-ventricular systolic dysfunction.

Authors:  T A McDonagh; S D Robb; D R Murdoch; J J Morton; I Ford; C E Morrison; H Tunstall-Pedoe; J J McMurray; H J Dargie
Journal:  Lancet       Date:  1998-01-03       Impact factor: 79.321

5.  Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.

Authors:  Alan S Maisel; Padma Krishnaswamy; Richard M Nowak; James McCord; Judd E Hollander; Philippe Duc; Torbjørn Omland; Alan B Storrow; William T Abraham; Alan H B Wu; Paul Clopton; Philippe G Steg; Arne Westheim; Catherine Wold Knudsen; Alberto Perez; Radmila Kazanegra; Howard C Herrmann; Peter A McCullough
Journal:  N Engl J Med       Date:  2002-07-18       Impact factor: 91.245

6.  B-type natriuretic peptide in cardiovascular disease.

Authors:  James A de Lemos; Darren K McGuire; Mark H Drazner
Journal:  Lancet       Date:  2003-07-26       Impact factor: 79.321

7.  Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study.

Authors:  Ramachandran S Vasan; Emelia J Benjamin; Martin G Larson; Eric P Leip; Thomas J Wang; Peter W F Wilson; Daniel Levy
Journal:  JAMA       Date:  2002-09-11       Impact factor: 56.272

Review 8.  Clinical applications of B-type natriuretic peptide (BNP) testing.

Authors:  M R Cowie; P Jourdain; A Maisel; U Dahlstrom; F Follath; R Isnard; A Luchner; T McDonagh; J Mair; M Nieminen; G Francis
Journal:  Eur Heart J       Date:  2003-10       Impact factor: 29.983

Review 9.  Natriuretic peptides in the pathophysiology of congestive heart failure.

Authors:  H H Chen; J C Burnett
Journal:  Curr Cardiol Rep       Date:  2000-05       Impact factor: 3.955
  9 in total
  10 in total

Review 1.  B-type natriuretic peptide as a parameter for pulmonary hypertension in children. A systematic review.

Authors:  Chantal A Ten Kate; Dick Tibboel; Ulrike S Kraemer
Journal:  Eur J Pediatr       Date:  2015-08-23       Impact factor: 3.183

2.  Factors affecting N-terminal pro-B-type natriuretic peptide levels in preterm infants and use in determination of haemodynamic significance of patent ductus arteriosus.

Authors:  Sarah Louise Harris; Kiran More; Bronwyn Dixon; Richard Troughton; Chris Pemberton; John Horwood; Nicola Ellis; Nicola Austin
Journal:  Eur J Pediatr       Date:  2018-01-19       Impact factor: 3.183

3.  Usefulness of natriuretic peptides in primary health care: an exploratory study in elderly patients.

Authors:  Mona Olofsson; Kurt Boman
Journal:  Scand J Prim Health Care       Date:  2010-03       Impact factor: 2.581

Review 4.  Gene replacement strategies to test the functional redundancy of basic helix-loop-helix transcription factor.

Authors:  Anthony B Firulli; Beth A Firulli; Jian Wang; Rhonda H Rogers; Simon J Conway
Journal:  Pediatr Cardiol       Date:  2010-02-14       Impact factor: 1.655

Review 5.  Potential role of biochemical markers in the prognosis of COVID-19 patients.

Authors:  Apeksha Niraula; Nirmal Baral; Madhab Lamsal; Mahima Bataju; Saroj Thapa
Journal:  SAGE Open Med       Date:  2022-07-05

6.  Diagnostic value of patterns of symptoms and signs of heart failure: application of latent class analysis with concomitant variables in a cross-sectional study.

Authors:  Milton Severo; Ana Rita Gaio; Patrícia Lourenço; Margarida Alvelos; Alexandra Gonçalves; Nuno Lunet; Paulo Bettencourt; Ana Azevedo
Journal:  BMJ Open       Date:  2012-11-12       Impact factor: 2.692

7.  Biomarkers in outpatient heart failure management; Are they correlated to and do they influence clinical judgment?

Authors:  J M P W U Peeters; S Sanders-van Wijk; S Bektas; C Knackstedt; P Rickenbacher; F Nietlispach; R Handschin; M T Maeder; S F Muzzarelli; M E Pfisterer; H P Brunner-La Rocca
Journal:  Neth Heart J       Date:  2014-03       Impact factor: 2.380

8.  Mannose binding lectin and macrophage migration inhibitory factor gene polymorphisms in Turkish children with cardiomyopathy: no association with MBL2 codon 54 A/B genotype, but an association between MIF -173 CC genotype.

Authors:  Nilgun Col-Araz; Sibel Oguzkan-Balci; Osman Baspinar; Tugce Sever; Ayse Balat; Sacide Pehlivan
Journal:  Int J Med Sci       Date:  2012-08-22       Impact factor: 3.738

9.  Using NT-proBNP as a criterion for heart failure hospitalization.

Authors:  Babak Tamizifar; Maryam Rismankarzadeh
Journal:  J Res Med Sci       Date:  2012-01       Impact factor: 1.852

10.  Biometric and Psychometric Remote Monitoring and Cardiovascular Risk Biomarkers in Ischemic Heart Disease.

Authors:  Chrisandra L Shufelt; Andy Kim; Sandy Joung; Lili Barsky; Corey Arnold; Susan Cheng; Shivani Dhawan; Garth Fuller; William Speier; Mayra Lopez; Mitra Mastali; Kelly Mouapi; Irene van den Broek; Janet Wei; Brennan Spiegel; Jennifer E Van Eyk; C Noel Bairey-Merz
Journal:  J Am Heart Assoc       Date:  2020-09-08       Impact factor: 6.106
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.